BR102020024378A2 - Synthetic peptide antigen p.sc2.s.309 applied in kit and elisa method for serological diagnosis of covid-19 - Google Patents
Synthetic peptide antigen p.sc2.s.309 applied in kit and elisa method for serological diagnosis of covid-19Info
- Publication number
- BR102020024378A2 BR102020024378A2 BR102020024378A BR102020024378A BR102020024378A2 BR 102020024378 A2 BR102020024378 A2 BR 102020024378A2 BR 102020024378 A BR102020024378 A BR 102020024378A BR 102020024378 A BR102020024378 A BR 102020024378A BR 102020024378 A2 BR102020024378 A2 BR 102020024378A2
- Authority
- BR
- Brazil
- Prior art keywords
- covid
- kit
- synthetic peptide
- test
- diagnostic
- Prior art date
Links
- 208000025721 COVID-19 Diseases 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000000405 serological effect Effects 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
Abstract
antígeno peptídeo sintético p.sc2.s.309 aplicado em kit e método elisa para diagnóstico sorológico de covid-19. frente ao panorama da pandemia de covid-19 há a necessidade de alternativas de diagnóstico. a presente invenção descreve um kit e método diagnóstico sorológico para covid-19. esta utiliza como antígeno o peptídeo sintético p.sc2.s.309 em imunoensaios no formato de teste elisa para identificar imunoglobulina igm em amostras biológicas de humanos, podendo também ser aplicada como teste de avidez. o peptídeo p.sc2.s.309 apresenta sequência artificial altamente similar ao do sars-cov-2 e de baixa similaridade com outros organismos próximos. este kit e seu método de uso apresentam alta sensibilidade (85%) e especificidade (100%) para detecção de igm. além de ser um teste de baixo custo e fácil execução, possibilitando um teste diagnóstico eficiente mais acessível.synthetic peptide antigen p.sc2.s.309 applied in kit and elisa method for serological diagnosis of covid-19. given the panorama of the covid-19 pandemic, there is a need for diagnostic alternatives. The present invention describes a serological diagnostic kit and method for covid-19. this uses the synthetic peptide p.sc2.s.309 as antigen in immunoassays in the elisa test format to identify igm immunoglobulin in biological samples from humans, and can also be applied as an avidity test. the peptide p.sc2.s.309 has an artificial sequence highly similar to that of sars-cov-2 and of low similarity to other nearby organisms. this kit and its method of use have high sensitivity (85%) and specificity (100%) for the detection of igm. in addition to being a low cost test and easy to perform, allowing an efficient diagnostic test more accessible.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102020024378-0A BR102020024378B1 (en) | 2020-11-30 | SYNTHETIC PEPTIDE ANTIGEN P.SC2.S.309 APPLIED IN KIT AND ELISA METHOD FOR SEROLOGICAL DIAGNOSIS OF COVID-19 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102020024378-0A BR102020024378B1 (en) | 2020-11-30 | SYNTHETIC PEPTIDE ANTIGEN P.SC2.S.309 APPLIED IN KIT AND ELISA METHOD FOR SEROLOGICAL DIAGNOSIS OF COVID-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
BR102020024378A2 true BR102020024378A2 (en) | 2022-05-10 |
BR102020024378B1 BR102020024378B1 (en) | 2023-08-22 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Elshemey et al. | Evaluation of a rapid immunochromatographic test for detection of Brucella abortus antibodies in Egyptian cattle sera and milk. | |
Samartino et al. | Validation of enzyme-linked immunosorbent assays for the diagnosis of bovine brucellosis | |
Rhodes et al. | Comparative study of IFNγ and antibody tests for feline tuberculosis | |
DE60331677D1 (en) | KIT FOR THE STUDY OF HUMAN LOW MOLECULAR WEIGHT CD14 AND ANTIBODIES | |
Hezarjaribi et al. | Serological evidence of human cystic echinococcosis and associated risk factors among general population in Mazandaran Province, northern Iran | |
ES512498A0 (en) | "METHOD AND ITS CORRESPONDING DEVICE FOR THE TESTING OF ANTIBODIES WITH RESPECT TO SOLUBLE ANTIGENS". | |
Day | Introduction to antigen and antibody assays | |
Julián et al. | An ELISA for five glycolipids from the cell wall of Mycobacterium tuberculosis:: Tween 20 interference in the assay | |
Kabeer et al. | Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection | |
Kumar et al. | Development of the Com1 synthetic peptide-based Latex Agglutination Test (LAT) and its comparative evaluation with commercial indirect-ELISA for sero-screening of coxiellosis in cattle | |
Cooper et al. | ELISA and immuno–polymerase chain reaction assays for the sensitive detection of melioidosis | |
García-Bocanegra et al. | Evaluation of different enzyme-linked immunosorbent assays for the diagnosis of brucellosis due to Brucella melitensis in sheep | |
BR102020024378A2 (en) | Synthetic peptide antigen p.sc2.s.309 applied in kit and elisa method for serological diagnosis of covid-19 | |
BR9507389A (en) | Method for detecting the presence of a mycobacterium species and a kit and antibodies for use in it | |
BR102020024403A2 (en) | Synthetic peptide antigens for the diagnosis of sars-cov-2 | |
ATE304607T1 (en) | DETECTION OF PYRUVATE KINASE ISOENZYME IN CHEESE | |
ATE282830T1 (en) | IMMUNE TEST FOR HUMAN CHROMOGRANINE A (CGA), ANTIBODIES, REAGENT AND SUITABLE TEST SET | |
Turner et al. | Serological speciation of human schistosome infections by ELISA with a panel of three antigens | |
Minas et al. | Validation of a competitive ELISA for diagnosis of Brucella melitensis infection in sheep and goats | |
Rodrigo et al. | A new application of Streptavidin ImmunoCAP® for measuring IgG antibodies against non-available commercial antigens | |
Redhuan et al. | Salivary anti-50 kDa antibodies as a useful biomarker for diagnosis of typhoid fever | |
Rokni et al. | Comparative evaluation of Fast enzyme linked immunosorbent assay (Fast-ELISA) and standard-ELISA for the diagnosis of human hydatidosis | |
Andrae et al. | Antigen detection in canine blastomycosis: comparison of different antibody-antigen combinations in two competitive ELISAs | |
Shaheen et al. | Evaluation of the response of human humoral antibodies to Salmonella typhi lipopolysaccharide in an area of endemic typhoid fever | |
van Knapen et al. | Detection of toxoplasma antigen in tissues by means of enzyme-linked immunosorbent assay (ELISA) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03B | Publication of an application: publication anticipated [chapter 3.2 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/11/2020, OBSERVADAS AS CONDICOES LEGAIS |
|
B22L | Other matters related to patents and certificates of addition of invention: notification of licence offer (art 64 par 1 of lpi) |
Free format text: CONDICOES CONTRATUAIS: 1) ROYALTIES: 5% (CINCO POR CENTO) DO PRECO DE VENDA, LIVRE DE IMPOSTOS; 2) PRAZO: ATE O TERMINO DE VIGENCIA DA PATENTE, EM 30/11/2040; 3) CONDICOES DE PAGAMENTO: ANUAL EM FUNCAO DAS VENDAS APURADAS NO PERIODO; 4) DISPONIBILIDADE DE "KNOW-HOW": SIM; 5) ASSISTENCIA TECNICA: NAO. --- OBS: CONSULTA A CARTA PATENTE PODERA SER FEITA ATRAVES DO ENDERECO ELETRONICO WWW.INPI.GOV.BR - NO ACESSO RAPIDO = BUSCA DE PROCESSOS = FACA LOGIN COM SENHA OU TECLE CONTINUAR = PATENTE = DIGITE O NUMERO DO PROCESSO = PESQUISAR. PARA ACESSAR, CADASTRE-SE NO PORTAL DO INPI. |
|
B22L | Other matters related to patents and certificates of addition of invention: notification of licence offer (art 64 par 1 of lpi) |
Free format text: CONDICOES CONTRATUAIS: 1) ROYALTIES: 5% (CINCO POR CENTO) DO PRECO DE VENDA, LIVRE DE IMPOSTOS; 2) PRAZO: ATE O TERMINO DE VIGENCIA DA PATENTE, EM 30/11/2040; 3) CONDICOES DE PAGAMENTO: ANUAL EM FUNCAO DAS VENDAS APURADAS NO PERIODO; 4) DISPONIBILIDADE DE KNOW-HOW: SIM; 5) ASSISTENCIA TECNICA: NAO. --- OBS: CONSULTA A CARTA PATENTE PODERA SER FEITA ATRAVES DO ENDERECO ELETRONICO WWW.INPI.GOV.BR - NO ACESSO RAPIDO = BUSCA DE PROCESSOS = FACA LOGIN COM SENHA OU TECLE CONTINUAR = PATENTE = DIGITE O NUMERO DO PROCESSO = PESQUISAR. PARA ACESSAR, CADASTRE-SE NO PORTAL DO INPI. |